[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The US AIDS Diagnostics Market: Test Volumes, Sales Forecasts, and Supplier Shares

October 2011 | 251 pages | ID: UCB97119463EN
Venture Planning Group

US$ 1,480.00 US$ 1,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
  • Hospitals
  • Commercial/Private Laboratories
  • Blood Banks
  • Physician Offices
  • Public Health Laboratories
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Ortho Clinical Diagnostics, Novartis, and Roche.

Highlights
  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immundiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.
Methodology

The report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 251 pages and 7 tables
I. INTRODUCTION

II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW


A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS'

Sales and Market Shares

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts
By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


More Publications